We are delighted to announce that the Edison Growth Conference 2025 will take place on Tuesday, 13 May 2025, 8:30 am - 2:00 pm at Saddlers' Hall, London EC2V 6BR. 📍 Following the success of last year’s event, this year’s half-day conference will once again feature three engaging panel discussions on critical themes: 🔹 AI and Automation 🤖🚀 🔹 Normalisation of Interest Rates 📈🏦 🔹 The Four-Trillion-Dollar Climate Opportunity 🌍💰 📅 Mark your calendar now for this must-attend event! #EdisonGrowthConference #Investment #AI #Climate #Finance Add to your Calendar: https://lnkd.in/eaM3MFVe
About us
As a content-led IR business, Edison helps companies stand out and meet the right shareholders. Edison’s integrated investor relations solution combines expert analyst content, digital targeting, and active investor engagement. This drives liquidity and valuations by building bigger, better informed, and more engaged investor audiences globally. Edison has a proven history of increasing liquidity and valuations for its clients. Edison’s content can be viewed by all investors, anywhere in the world. Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584).
- Website
-
http://www.edisongroup.com
External link for Edison Group
- Industry
- Financial Services
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2003
- Specialties
- Research, Commercial Due Diligence, Institutional Investor, Investor Relations , Investment Research, Financial Services, Digital IR, Capital Markets, and IPO
Locations
-
Primary
20 Red Lion Street
London, England WC1R 4PQ, GB
-
Level 4, Office 1205
95 Pitt Street
Sydney, NSW 2000, AU
-
1185 Avenue of Americas
3rd Floor
New York, New York 10036, US
-
Schumannstrasse 34b
Frankfurt, 60325, DE
Employees at Edison Group
Updates
-
With a market capitalisation of nearly A$100m, Actinogen Medical (ASX: ACW) is an innovative clinical-stage #Australian #biotech company pioneering the development of #Xanamem, a novel therapeutic drug candidate targeting #Alzheimer’s disease and major depressive disorder. Xanamem, also known as #emestedastat, is a first-in-class, brain-penetrant cortisol inhibitor, and it is the only molecule of its kind in advanced-stage clinical #trials for Alzheimer’s. Read the latest report here: https://lnkd.in/g7EJRTbQ Watch the video below 👇 Jyoti Prakash, CFA #ACW #ASX
-
Edison Group is arranging investor meetings with Gervais Williams, Fund Manager of the THE DIVERSE INCOME TRUST PLC. Gervais will be available for meetings in: London on 14th May Channel Islands on 15th May If you would like to arrange a meeting, please contact: kpoynter@edisongroup.com For our latest research on the Diverse Income Trust, https://lnkd.in/erKM9u8S
-
-
In our interview, Richard Hutton, CFO of Greggs, provides an overview of some of the long-term growth drivers for the business and required changes to the infrastructure, before focusing on the current trading environment and outlook for the year ahead. We begin with the long-term growth opportunity for Greggs from a space perspective, beyond the current five-year growth strategy under which the company is aiming to #doubleRevenue. Richard then talks about how Greggs’ #digitalTransformation activities are helping to drive #revenueGrowth and improve its #customerRelationshipManagement capabilities. Next, he describes current #capitalInvestment in a number of #infrastructureProjects that will help to support the company’s #futureGrowth. We move on to how the addition of #newProducts and #newServices is increasing the complexity of #inStoreOperations. Richard concludes by providing some insights into the current #operatingEnvironment and the #outlook for the year. Watch the full interview here: https://lnkd.in/g9VQw7eh #LSE #GRG Russell Pointon, CFA ACA
-
HgT has delivered an 18% average NAV total return per year in recent years – a testament to its focused strategy in backing B2B software and IT services firms. With a portfolio centred on founder-led, unquoted tech businesses, HgT continues to generate long-term value by investing in resilient, high-performing companies. Want to understand how consistent returns are being delivered in this space? Read the latest Edison update: https://lnkd.in/esRyNZcG #TechInvesting #HGCapitalTrust #GrowthStrategy
-
Edison Group reposted this
𝗖𝗮𝗽𝗶𝘁𝗮𝗹 𝗠𝗮𝗿𝗸𝗲𝘁𝘀 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 – 𝗘𝗶𝗻 𝗧𝗮𝗴 𝘃𝗼𝗹𝗹𝗲𝗿 𝗘𝗶𝗻𝗯𝗹𝗶𝗰𝗸𝗲 Beim Capital Markets Day konnten unsere Investorinnen und Investoren die PORR hautnah erleben – mit exklusiven Einblicken in zwei beeindruckende Bauprojekte und spannenden Gesprächen mit unserem Top-Management 📊🏗️ 🚇 𝗘𝗿𝘀𝘁𝗲𝗿 𝗦𝘁𝗼𝗽𝗽: Die U2-Baustelle Matzleinsdorfer Platz – ein Infrastrukturprojekt, das die Zukunft des öffentlichen Verkehrs in Wien prägt. 🏙️ 𝗭𝘄𝗲𝗶𝘁𝗲𝗿 𝗛𝗮𝗹𝘁: Das LeopoldQuartier, unser Vorzeigeprojekt für nachhaltiges und innovatives Bauen, das neue Maßstäbe setzt. Ein besonderes Highlight: PORR CEO Karl-Heinz Strauss und CFO Klemens Eiter nahmen sich persönlich Zeit, um über aktuelle Entwicklungen, Strategien und Zukunftspläne der PORR Group zu sprechen. Vielen Dank an alle Teilnehmerinnen und Teilnehmer für den inspirierenden Austausch – wir freuen uns auf das nächste Mal. ___ 𝗖𝗮𝗽𝗶𝘁𝗮𝗹 𝗠𝗮𝗿𝗸𝗲𝘁𝘀 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 – 𝗔 𝗱𝗮𝘆 𝗳𝘂𝗹𝗹 𝗼𝗳 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 At our Capital Markets Day this week, our investors were able to experience PORR up close – with exclusive insights into two impressive construction projects and exciting discussions with our top management 📊🏗️ 🚇 𝗙𝗶𝗿𝘀𝘁 𝘀𝘁𝗼𝗽: the U2 underground line construction site at Matzleinsdorfer Platz – an infrastructure project that will shape the future of public transport in Vienna. 🏙️ 𝗦𝗲𝗰𝗼𝗻𝗱 𝘀𝘁𝗼𝗽: LeopoldQuartier, our flagship project for sustainable and innovative construction that is setting new standards. A particular highlight: our CEO Karl-Heinz Strauss and CFO Klemens Eiter personally took time out of their busy schedules to talk about the PORR Group's current developments, strategies and future plans. Many thanks to all participants for the inspiring exchange – we look forward to the next time. #PORRGroup #HomeOfConstruction #InvestorRelations #CapitalMarketsDay
-
We want your input. Take five minutes to complete our investor survey and help shape the content and research we create for you. As a thank you, you’ll be entered into our spring prize draw to win a luxury Fortnum & Mason hamper. Based outside the UK? You’ll receive a £350 gift card of your choice instead. The winner will be selected at random and notified by email by 12.30pm on Wednesday 30 April. 👉 Take the survey now: http://bit.ly/41TYnds
-
Mendus AB (OMX: IMMU) is a clinical-stage immuno-oncology company based in #Sweden and the #Netherlands. It is focused on developing active #immunotherapies to improve long-term survival in #cancers, including blood-borne #tumours, that are underserved by current #immunotherapies, such as immune checkpoint inhibitors. The company’s lead clinical programme, #vididencel, is an off-the-shelf cellular immunotherapy that is being developed as a maintenance therapy for acute myeloid leukaemia (AML). Read the latest report here: https://lnkd.in/gWW9FQBh Jyoti Prakash, CFA Arron Aatkar, PhD #IMMU #OMX
-
Thank you to the The Investor Relations Society for holding an insightful session yesterday on Targeting and Engaging with Different Stakeholders. The discussions offered valuable perspectives across geographical landscapes and evolving capital pools. Edison’s CEO, Fraser Thorne discussed the importance of the private investor, who play an increasingly influential role in equity markets. A timely reminder of the importance for corporates to remain front of mind with investors, continuously articulating and reinforcing their equity story in a competitive capital markets environment. Thank you to Jane Henderson and BAT for hosting at your fantastic offices. London certainly looked beautiful in the sunshine yesterday. If you need to ramp up your investor engagement do contact Edison Group iruk@edisongroup.com Fraser Thorne Pip Bean (Wiggin) Kelly Poynter
-
-
Get the lowdown from Edison’s Milosz Papst on Patria Private Equity Trust PLC which allows #investors to gain exposure to a gradually rebounding private #equity market via a trust active in the attractive mid-market (primarily in #Europe), which has delivered strong five- and 10-year annualised NAV total #returns of 15.3% and 15.0% pa, respectively. #PPET #LSE Read the latest report here: https://lnkd.in/d3bJhTEj